CAMBRIDGE, Mass., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today ...
NEW YORK--(BUSINESS WIRE)--Flatiron Health today announced their planned presence at this year’s San Antonio Breast Cancer Symposium (SABCS), including four accepted abstracts for poster presentation ...
In an era dominated by algorithms and automation, new research from the University of Miami Patti and Allan Herbert Business ...
NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI ® (ublituximab-xiiy) data in patients ...
TG Therapeutics, Inc. has announced its schedule for presenting data on BRIUMVI® (ublituximab-xiiy) at the upcoming American Academy of Neurology 2025 annual meeting in San Diego, California, from ...
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today announced that new preclinical data on SGR-3515, its investigational Wee1/Myt1 inhibitor, and SGR-4174, its SOS1 inhibitor, will be ...
Regeneron presents real-world data on EYLEA HD's effectiveness and economic benefits in treating retinal diseases at ARVO 2025. Regeneron Pharmaceuticals announced the upcoming presentation of data on ...
LAREDO, Tex. (KGNS) - The Alzheimer’s Association will host a community presentation Sept. 22 in Laredo to share the latest developments in research and treatment options for Alzheimer’s disease. The ...
Spend less time wrangling data and more time uncovering opportunities with Bloomberg’s growing number of investment research data products. Purpose-built and curated for rigorous investment research, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback